您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
REA / Bioactive Compounds

Human GITRL/TNFSF18 Protein (N-His-Avi)

Human GITRL/TNFSF18 Protein (N-His-Avi)

英诺赛图(InnoCyto)的 Human GITRL/TNFSF18 Protein (N-His-Avi),属于生物活性物质,靶点/物种 TNFSF18(别名 GITR Ligand 等),表达宿主 CHO,N-His-Avi 标签,纯度 >95% based on SDS-PAGE under reducing condition,适用于酶联免疫(ELISA)。提供 25 μg、100 μg 规格,目录价 ¥983 起,仅供科研使用(RUO)。

科学仪器 供应商 上海英诺赛图 ↗ 型号 606601 更新 2026-11-12
参考价格区间
¥983
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Human GITRL/TNFSF18 Protein (N-His-Avi),属于生物活性物质,靶点/物种 TNFSF18(别名 GITR Ligand 等),表达宿主 CHO,N-His-Avi 标签,纯度 >95% based on SDS-PAGE under reducing condition,适用于酶联免疫(ELISA)。提供 25 μg、100 μg 规格,目录价 ¥983 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

606601 | 25 μg | ¥983

606602 | 100 μg | ¥2,000

Product Details

Molecular Weight|This prtoein has the predicted molecular weight of 18.3 kD. Under DTT-reducing conditions, the protein migrates at approximately 20 kD on SDS-PAGE

Regulatory Status|RUO

Protein Concentration|25µg size is bottled at 0.2mg/mL concentration. 100 µg size is supplied at a lot-specific concentration.

Storage and Handling|Briefly centrifuge the vial upon receipt. An unopened vial can be stored at 4°C for up to 2 weeks, or at -20°C or below for up to six months. The protein may be further diluted to 0.1 mg/mL using 0.22 µm-filtered PBS buffer (pH 7.4). For long-term storage, the diluted stock solution should be aliquoted and stored at ≤ –70°C to minimize freeze-thaw cycles. If additional dilution is required, carrier proteins such as FBS or BSA should be added to maintain protein stability.

Background Information

Glucocorticoid-Induced TNF Receptor Ligand (GITRL), also known as TNFSF18, is a member of the tumor necrosis factor (TNF) ligand superfamily. It functions as the cognate ligand for GITR (Glucocorticoid-Induced TNFR-Related protein, or TNFRSF18), an immunoregulatory receptor expressed primarily on activated T cells, regulatory T cells (Tregs), and natural killer (NK) cells. The GITR–GITRL interaction plays a key role in modulating immune responses, particularly in balancing immune activation and tolerance. Engagement of GITR by GITRL activates costimulatory signaling that enhances T cell proliferation, survival, and cytokine production, while weakening Treg-mediated suppression, thereby amplifying immune responses under certain conditions.

Structurally, GITRL is a type II transmembrane protein consisting of a short N-terminal cytoplasmic domain, a transmembrane domain, and a C-terminal extracellular domain responsible for receptor binding. The extracellular region adopts a characteristic TNF homotrimeric structure, composed of three GITRL monomers forming a bell-shaped complex that interacts symmetrically with three GITR receptor subunits. This trimeric configuration is essential for effective receptor clustering and downstream signal transduction. In some species, including humans, soluble forms of GITRL also exist and can modulate signaling in a concentration-dependent manner, though their physiological roles remain less fully understood.

Functionally, GITRL acts primarily as a costimulatory molecule that modulates both innate and adaptive immunity. It is expressed on antigen-presenting cells such as dendritic cells, macrophages, and B cells, as well as on endothelial cells following inflammatory stimuli. Its main receptor, GITR, signals through TRAF family adaptor proteins to activate NF-κB and MAPK pathways, leading to T cell activation and cytokine secretion. Through these effects, GITRL contributes to immune regulation but may also exacerbate inflammation or autoimmunity if dysregulated.

In disease contexts, aberrant GITR–GITRL signaling has been linked to autoimmunity, chronic inflammation, and cancer. Overactivation of this pathway can promote effector T cell activity and reduce Treg-mediated tolerance, contributing to autoimmune conditions such as rheumatoid arthritis and lupus. Conversely, in cancer, GITRL engagement enhances anti-tumor immunity by revitalizing T cells in the tumor microenvironment. Consequently, GITR agonists and GITRL-based therapies are being explored in immuno-oncology to potentiate immune responses against tumors, while GITR pathway inhibitors might offer therapeutic benefit in autoimmune disorders.

Data Sheets

Human GITRL (TNFSF18) (N-His-Avi) on SDS-PAGE under reducing condition (P+) and non-reducing condition (P-). The gel was stained for 1 hour with BlinkBlue (catalog 700102). The purity of this protein appears to be greater than 95%.

规格明细:Storage and Handling — Briefly centrifuge the vial upon receipt. An unopened vial can be stored at 4°C for up to 2 weeks, or at -20°C or below for up to six months. The protein may be further diluted to 0.1 mg/mL using 0.22 µm-filtered PBS buffer (pH 7.4). For long-term storage, the diluted stock solution should be aliquoted and stored at ≤ –70°C to minimize freeze-thaw cycles. If additional dilution is required, carrier proteins such as FBS or BSA should be added to maintain protein stability.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 μg
ApplicationELISA, BLI
FormatLiquid, Purified
Expression HostCHO
Target NameTNFSF18, GITR Ligand, AITRL, TL6, GITRL
SpeciesHuman
Accession NumberQ9UNG2
SourcesRecombinant Human TNFSF18 (Glu52-Ser177) with N-terminus His-Avi tag is expressed in CHO cells.
Affinity TagN-His-Avi
Purity>95% based on SDS-PAGE under reducing condition
Regulatory StatusRUO
Formulation1xPBS buffer, pH7.4, 0.22 µm filtered
Endotoxin levelLess than 0.1 EU/µg protein as determined by the LAL method
Protein Concentration25µg size is bottled at 0.2mg/mL concentration. 100 µg size is supplied at a lot-specific concentration.
目录价¥983

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Human GITRL/TNFSF18 Protein (N-His-Avi)(606601)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/human-gitrl-tnfsf18-protein-n-his-avi.html.
TeleVM. (2026, November 12). Human GITRL/TNFSF18 Protein (N-His-Avi)(606601). 产品目录. https://www.suprotek.cn/products/item/human-gitrl-tnfsf18-protein-n-his-avi.html
@misc{biocsp_item_human_gitrl_tnfsf18_protein_n_his_avi,
  title        = {Human GITRL/TNFSF18 Protein (N-His-Avi)(606601)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/human-gitrl-tnfsf18-protein-n-his-avi.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Human GITRL/TNFSF18 Protein (N-His-Avi)

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。